Reading Room

Recommendations for Contraceptive Use

Previous PageTable Of Contents


Oral Contraceptives as Emergency Contraceptive Pills


Classification of Selected Procedures for oral contraceptives (OCs) as Emergency Contraceptive Pills (ECPs)

Procedure Class Rationale
Pelvic examination (speculum and bimanual) C
  • Established pregnancy, the only condition which would restrict use of COCs, should be identified by history before method initiation. A pelvic exam is not necessary to ensure safe use of short-term COCs1,2.
  • When a pelvic exam is necessary to help evaluate the possibility of pregnancy, then it becomes Class A.
Blood pressure C Because of the short duration of the ECP regimen, it is highly unlikely that ECPs would have adverse effects 3.
Breast examination C A breast exam is not necessary to ensure the safe use of OCs or ECPs. While any hormonal treatment may in theory cause a pre-existing lump to grow it is highly unlikely that ECPs will affect the preexisting condition, due to the short duration of the regimen1,3.
Sexually transmitted disease (STD) screening by lab tests (for asymptomatic persons) C STD screening by lab tests for asymptomatic clients is not necessary for the safe, short-term use of COCs1.
Cervical cancer screening C Cervical cancer screening is unrelated to ECP use.
Routine, mandatory lab tests (e.g., cholesterol, glucose, liver function tests) D The effects of COCs on cholesterol, blood glucose and normal liver function are slight, and of no demonstrated clinical significance4.
Proper infection prevention procedures C Proper infection prevention procedures are not applicable to ECP use.
Specific counseling points for ECP use: A
  • Counseling is essential for the client to make an informed choice.
  • efficacy
 
  • Accurate client education regarding efficacy is necessary to prepare the client for the possible failure of the method and subsequent pregnancy5.
  • correct use of the method (including instructions for vomited pills)
 
  • In the event of ECPs failure, counseling on the absence of known risk of ECPs on fetal development, and referral to follow-up care, are necessary.
  • what to do in the event ECPs fail
  • follow-up schedule
  • information on other contraceptive methods and time of initiation
 
  • Lower abdominal pain, abnormally light, heavy or short bleeding, and the absence of a menstrual period three weeks after using ECPs are signs that a woman could be pregnant or experiencing an ectopic pregnancy. Both of these situations require medical attention6.
  • signs and symptoms for which to see a health provider
 
  • Appropriate counseling about common side effects of ECPs will prepare the client for the potential uncomfortable side effects and help her effectively manage them.
  • common side effects (including potential disruption of menstrual cycle)
 
  • ECPs commonly cause a disruption in the length of the next menstrual cycle7. The client needs to be aware of this temporary disturbance because the arrival of the menstrual period will signify that she is not pregnant.
  • STD protection (when/as appropriate)
 
  • When time permits and the situation is appropriate, the client should be counseled on STD protection because the "unprotected" act of intercourse was unprotected from infection as well as from pregnancy.

KEY:

Class A = essential and mandatory or otherwise important in all circumstances, for safe and effective use of the contraceptive method

Class B = medically/epidemiologically rational in some circumstances to optimize the safe and effective use of the contraceptive method, but may not be appropriate for all clients in all settings

Class C = may be appropriate for good preventive health care, but not materially related to safe and effective use of the contraceptive method

Class D = not materially related to either good routine preventive health care or safe and effective use of the contraceptive method

Citations for Procedures Table:

  1. World Health Organization. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. Geneva: WHO, 1996.
  2. Program for Appropriate Technology in Health. Emergency contraception: a resource manual for providers. Seattle: PATH, 1997.
  3. Glasier A. Emergency Contraception: time for deregulation? British Journal of Obstetrics and Gynaecology 1993;100:611-2.
  4. Speroff L, Glass R, and Kase N. Clinical gynecologic endocrinology and infertility, 5th edition. Baltimore: Williams and Wilkins, 1994.
  5. Potter L. Oral contraceptive compliance and its role in the effectiveness of the method. In: Cramer J, Spilker B. Patient compliance in medical practice and clinical trials. New York: Raven Press, Ltd., 1991.
  6. CSAC. Emergency (postcoital) contraception guidelines for doctors. British Journal of Family Planning 1992;13(3):centrefold.
  7. Haspels A. Emergency contraception: a review. Contraception 1994;50:101-9.

Any part of Recommendations for Updating Selected Practices in Contraceptive Use may be reproduced or adapted to meet local needs without prior permission from the TG/CWG Secretariat, provided the TG/CWG is acknowledged and the material is made available free of charge or at cost.


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website

Top Of Page